SVB Wealth LLC Reduces Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

SVB Wealth LLC reduced its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 4.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 19,520 shares of the medical instruments supplier’s stock after selling 894 shares during the period. SVB Wealth LLC’s holdings in DENTSPLY SIRONA were worth $695,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of XRAY. MetLife Investment Management LLC boosted its stake in shares of DENTSPLY SIRONA by 23.1% during the first quarter. MetLife Investment Management LLC now owns 59,453 shares of the medical instruments supplier’s stock valued at $2,926,000 after purchasing an additional 11,156 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in DENTSPLY SIRONA by 6.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,250 shares of the medical instruments supplier’s stock worth $1,440,000 after acquiring an additional 1,811 shares in the last quarter. Raymond James Trust N.A. increased its position in shares of DENTSPLY SIRONA by 61.7% during the first quarter. Raymond James Trust N.A. now owns 7,042 shares of the medical instruments supplier’s stock worth $346,000 after acquiring an additional 2,687 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of DENTSPLY SIRONA by 6.9% during the first quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock valued at $90,243,000 after acquiring an additional 117,571 shares in the last quarter. Finally, Sei Investments Co. boosted its holdings in shares of DENTSPLY SIRONA by 18.9% in the first quarter. Sei Investments Co. now owns 468,759 shares of the medical instruments supplier’s stock valued at $23,090,000 after purchasing an additional 74,629 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on XRAY. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Barrington Research reaffirmed an “outperform” rating and issued a $41.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday. Piper Sandler increased their target price on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a report on Friday, January 12th. Finally, Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Moderate Buy” and an average price target of $39.50.

Check Out Our Latest Report on DENTSPLY SIRONA

DENTSPLY SIRONA Trading Up 0.2 %

XRAY opened at $30.50 on Friday. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.55. The business’s 50-day moving average is $32.79 and its two-hundred day moving average is $32.84. DENTSPLY SIRONA Inc. has a 1 year low of $26.27 and a 1 year high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The company’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.46 EPS. Sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were given a $0.16 dividend. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.10%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -103.22%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.